155 related articles for article (PubMed ID: 2700113)
21. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
22. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
Pasotti C; Capra A; Fiorella G; Vibelli C; Chierichetti SM
Br J Clin Pharmacol; 1982; 13(Suppl 2):435S-439S. PubMed ID: 7104157
[TBL] [Abstract][Full Text] [Related]
23. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
[TBL] [Abstract][Full Text] [Related]
24. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
25. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
26. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
van Baak MA; Böhm RO; Arends BG; van Hooff ME; Rahn KH
Int J Sports Med; 1987 Oct; 8(5):342-7. PubMed ID: 2890591
[TBL] [Abstract][Full Text] [Related]
27. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
[TBL] [Abstract][Full Text] [Related]
28. Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.
Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Maiwald C
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):597-604. PubMed ID: 2905341
[TBL] [Abstract][Full Text] [Related]
29. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
30. The effect of beta-blockers on mental performance on older hypertensive patients.
Gengo FM; Fagan SC; de Padova A; Miller JK; Kinkel PR
Arch Intern Med; 1988 Apr; 148(4):779-84. PubMed ID: 3281618
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension.
Neusy AJ; Valeri A
J Hum Hypertens; 1990 Aug; 4(4):453-7. PubMed ID: 2258893
[TBL] [Abstract][Full Text] [Related]
33. Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
Ke YS; Tao YY; Yang H; Yu GH
Acta Pharmacol Sin; 2003 Apr; 24(4):337-41. PubMed ID: 12676074
[TBL] [Abstract][Full Text] [Related]
34. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Herpin D; Guillard O; Piriou A; Amiel A; Boutaud P; Ciber MA; Demange J
Ann Med Interne (Paris); 1988; 139(7):484-7. PubMed ID: 3072894
[TBL] [Abstract][Full Text] [Related]
35. Effect of mepindolol on serum lipids.
Martignoni A; Perani G; Finardi G; Mastropasqua E; Fogari R
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):543-5. PubMed ID: 7174157
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
37. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
38. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
[TBL] [Abstract][Full Text] [Related]
39. Partial regression of vascular structural alterations in hypertensive patients treated with alpha-beta-blocker, labetalol.
Novo S; Abrignani MG; Sapienza ND; Barbagallo M; Pinto A; Di Maria GU; Mistretta A; Strano A
Int Angiol; 1992; 11(2):137-41. PubMed ID: 1402218
[TBL] [Abstract][Full Text] [Related]
40. Circadian rhythm of blood pressure and calcium entry blockade: a chronobiologic study with nitrendipine in essential hypertension.
Mele D; Manfredini R; Amadei GA; Sgobino P; Longhini C; Fersini C
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S51-4. PubMed ID: 1723456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
